Expression and function of protein A in Staphylococcus pseudintermedius

References

• Ross Fitzgerald J. The Staphylococcus Intermedius Group of Bacterial Pathogens: Species Re‐Classification, Pathogenesis and the Emergence of Meticillin Resistance. Vet Dermatol. 2009;20(5–6):490–495.
   PubMed Web of Science ®Google Scholar
• Van Duijkeren E, Catry B, Greko C, et al. Review on Methicillin-Resistant Staphylococcus Pseudintermedius. J Antimicrob Chemotherx. 2011;66(12):2705–2714. doi:10.1093/jac/dkr367.
   PubMed Web of Science ®Google Scholar
• Couto N, Martins J, Lourenço AM, et al. Identification of Vaccine Candidate Antigens of Staphylococcus Pseudintermedius by Whole Proteome Characterization and Serological Proteomic Analyses. J Proteomics. 2016;133:113–124. doi:10.1016/j.jprot.2015.12.017.
   PubMed Web of Science ®Google Scholar
• Bannoehr J, Guardabassi L. Staphylococcus Pseudintermedius in the Dog: Taxonomy, Diagnostics, Ecology, Epidemiology and Pathogenicity. Vet Dermatol. 2012;23(4):253–e52. doi:10.1111/j.1365-3164.2012.01046.x.
   PubMed Web of Science ®Google Scholar
• Beck KM, Waisglass SE, Dick HL, et al. Prevalence of Meticillin‐Resistant Staphylococcus Pseudintermedius (Mrsp) from Skin and Carriage Sites of Dogs after Treatment of Their Meticillin‐Resistant or Meticillin‐Sensitive Staphylococcal Pyoderma. Veterinary Dermatology. 2012;23(4):369–e67. doi:10.1111/j.1365-3164.2012.01035.x.
   PubMed Web of Science ®Google Scholar
• Beever L, Bond R, Graham PA, et al. Increasing Antimicrobial Resistance in Clinical Isolates of Staphylococcus Intermedius Group Bacteria and Emergence of Mrsp in the Uk. The Veterinary Record. 2015;176(7):172–172. doi:10.1136/vr.102651.
   PubMed Web of Science ®Google Scholar
• Feng Y, Tian W, Lin D, et al. Prevalence and Characterization of Methicillin-Resistant Staphylococcus Pseudintermedius in Pets from South China. Veterinary Microbiology. 2012;160(3):517–524.
   PubMed Web of Science ®Google Scholar
• Haenni M, de Moraes NA, Châtre P, et al. Characterisation of Clinical Canine Meticillin-Resistant and Meticillin-Susceptible Staphylococcus Pseudintermedius in France. Journal of Global Antimicrobial Resistance. 2014;2(2):119–123. doi:10.1016/j.jgar.2014.02.002.
   PubMed Web of Science ®Google Scholar
• Nienhoff U, Kadlec K, Chaberny IF, et al. Methicillin-Resistant Staphylococcus Pseudintermedius among Dogs Admitted to a Small Animal Hospital. Veterinary Microbiology. 2011;150(1):191–197.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang J, Logue CM, et al. Methicillin‐Resistant Staphylococcus Pseudintermedius Isolated from Canine Pyoderma in North China. Journal of Applied Microbiology. 2012;112(4):623–630. doi:10.1111/j.1365-2672.2012.05233.x.
   PubMed Web of Science ®Google Scholar
• Ruscher C, Lübke-Becker A, Wleklinski CG, et al. Prevalence of Methicillin-Resistant Staphylococcus Pseudintermedius Isolated from Clinical Samples of Companion Animals and Equidaes. Veterinary Microbiology. 2009;136(1):197–201.
   PubMed Web of Science ®Google Scholar
• Moodley A, Damborg P, Nielsen SS. Antimicrobial Resistance in Methicillin Susceptible and Methicillin Resistant Staphylococcus Pseudintermedius of Canine Origin: Literature Review from 1980 to 2013. Veterinary Microbiology. 2014;171(3):337–341.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Kikuchi K, Tanaka Y, et al. Methicillin-Resistant Staphylococcus Pseudintermedius in a Veterinary Teaching Hospital. Journal of Clinical Microbiology. 2007;45(4):1118–1125. doi:10.1128/JCM.02193-06.
   PubMed Web of Science ®Google Scholar
• Dos Santos TP, Damborg P, Moodley A, et al. Systematic Review on Global Epidemiology of Methicillin-Resistant Staphylococcus Pseudintermedius: Inference of Population Structure from Multilocus Sequence Typing Data. Front Microbiol. 2016;7.
   Web of Science ®Google Scholar
• Bannoehr J, Ben Zakour NL, Reglinski M, et al. Genomic and Surface Proteomic Analysis of the Canine Pathogen Staphylococcus Pseudintermedius Reveals Proteins That Mediate Adherence to the Extracellular Matrix. Infection and Immunity. 2011;79(8):3074–3086. doi:10.1128/IAI.00137-11.
   PubMed Web of Science ®Google Scholar
• Solyman S, Black CC, Duim B, et al. Multilocus Sequence Typing for Characterization of Staphylococcus Pseudintermedius. Journal of Clinical Microbiology. 2013;51(1):306–310. doi:10.1128/JCM.02421-12.
   PubMed Web of Science ®Google Scholar
• Perreten V, Kadlec K, Schwarz S, et al. Clonal Spread of Methicillin-Resistant Staphylococcus Pseudintermedius in Europe and North America: An International Multicentre Study. J Antimicrob Chemother. 2010;dkq078.
   Web of Science ®Google Scholar
• Black C, Solyman SM, Eberlein LC, et al. Identification of a Predominant Multilocus Sequence Type, Pulsed-Field Gel Electrophoresis Cluster, and Novel Staphylococcal Chromosomal Cassette in Clinical Isolates of Meca-Containing, Methicillin-Resistant Staphylococcus Pseudintermedius. Veterinary Microbiology. 2009;139(3):333–338.
   PubMed Web of Science ®Google Scholar
• Videla R, Solyman SM, Brahmbhatt A, et al. Clonal Complexes and Antimicrobial Susceptibility Profiles of Staphylococcus Pseudintermedius Isolates from Dogs in the United States. Microbial Drug Resistance. 2017. [Epub ahead of print]. doi:10.1089/mdr.2016.0250.
   PubMed Web of Science ®Google Scholar
• Foster TJ. Immune Evasion by Staphylococci. Nature Reviews Microbiology. 2005;3(12):948–958.
   PubMed Web of Science ®Google Scholar
• Kim HK, Thammavongsa V, Schneewind O, et al. Recurrent Infections and Immune Evasion Strategies of Staphylococcus Aureus. Current Opinion in Microbiology. 2012;15(1):92–99. doi:10.1016/j.mib.2011.10.012.
   PubMed Web of Science ®Google Scholar
• Rooijakkers, SH, Van Kessel KP, Van Strijp JA. Staphylococcal Innate Immune Evasion. Trends in Microbiology. 2005;13(12):596–601. doi:10.1016/j.tim.2005.10.002.
   PubMed Web of Science ®Google Scholar
• Forsgren A. Significance of Protein a Production by Staphylococci. Infection and Immunity. 1970;2(5):672.
   PubMedGoogle Scholar
• Sjöquist J, Movitz J, Johansson IB, et al. Localization of Protein a in the Bacteria. European Journal of Biochemistry. 1972;30(1):190–194. doi:10.1111/j.1432-1033.1972.tb02086.x.
   PubMedGoogle Scholar
• Björk, I, Petersson BÅ, Sjöquist J. Some Physicochemical Properties of Protein a from Staphylococcus Aureus. European Journal of Biochemistry. 1972;29(3):579–584. doi:10.1111/j.1432-1033.1972.tb02024.x.
   PubMedGoogle Scholar
• Movitz J. Formation of Extracellular Protein a by Staphylococcus Aureus. European Journal of Biochemistry. 1976;68(1):291–299. doi:10.1111/j.1432-1033.1976.tb10788.x.
   PubMedGoogle Scholar
• Lindmark R, Movitz J, Sjöquist J. Extracellular Protein a from a Methicillin‐Resistant Strain of Staphylococcus Aureus. European Journal of Biochemistry. 1977;74(3):623–628. doi:10.1111/j.1432-1033.1977.tb11431.x.
   PubMedGoogle Scholar
• Becker S, Frankel MB, Schneewind O, et al. Release of Protein a from the Cell Wall of Staphylococcus Aureus. Proceedings of the National Academy of Sciences. 2014;111(4):1574–1579. doi:10.1073/pnas.1317181111.
   PubMed Web of Science ®Google Scholar
• Forsgren A, Sjöquist J. “Protein a” from S. Aureus I. Pseudo-Immune Reaction with Human Γ-Globulin. The Journal of Immunology. 1966;97(6):822–827.
   PubMed Web of Science ®Google Scholar
• Kronvall G, Frommel D. Definition of Staphylococcal Protein a Reactivity for Human Immunoglobulin G Fragments. Immunochemistry. 1970;7(1):124IN19127–126IN20. doi:10.1016/0019-2791(70)90036-4.
   Google Scholar
• Dossett JH, Kronvall G, Williams RC Jr, et al. Antiphagocytic Effects of Staphylococcal Protein A. J Immunol. 1969;103(6):1405–1410.
   Web of Science ®Google Scholar
• Silverman GJ, Goodyear CS. A Model B-Cell Superantigen and the Immunobiology of B Lymphocytes. Clinical Immunology. 2002;102(2):117–134. doi:10.1006/clim.2001.5143.
   PubMed Web of Science ®Google Scholar
• Kristiansen SV, Pascual V, Lipsky PE. Staphylococcal Protein a Induces Biased Production of Ig by Vh3-Expressing B Lymphocytes. The Journal of Immunology. 1994;153(7):2974–2982.
   PubMed Web of Science ®Google Scholar
• Silverman GJ, Goodyear CS. Confounding B-Cell Defences: Lessons from a Staphylococcal Superantigen. Nature Reviews Immunology. 2006;6(6):465–75. doi:10.1038/nri1853.
   PubMed Web of Science ®Google Scholar
• Palmqvist N, Silverman GJ, Josefsson E, et al. Bacterial Cell Wall-Expressed Protein a Triggers Supraclonal B-Cell Responses Upon in Vivo Infection with Staphylococcus Aureus. Microbes and Infection. 2005;7(15):1501–1511. doi:10.1016/j.micinf.2005.05.008.
   PubMed Web of Science ®Google Scholar
• Daum RS, Spellberg B. Progress toward a Staphylococcus Aureus Vaccine. Clinical Infectious Diseases. 2012;54(4):560–7. doi:10.1093/cid/cir828.
   PubMed Web of Science ®Google Scholar
• Kim HK, Emolo C, DeDent AC, et al. Protein a-Specific Monoclonal Antibodies and Prevention of Staphylococcus Aureus Disease in Mice. Infection and Immunity. 2012;80(10):3460–3470. doi:10.1128/IAI.00230-12.
   PubMed Web of Science ®Google Scholar
• Kim HK, Cheng AG, Kim HY, et al. Nontoxigenic Protein a Vaccine for Methicillin-Resistant Staphylococcus Aureus Infections in Mice. Journal of Experimental Medicine. 2010;207(9):1863–1870. doi:10.1084/jem.20092514.
   PubMed Web of Science ®Google Scholar
• Kim HK, Emolo C, Missiakas D, et al. A Monoclonal Antibody That Recognizes the E Domain of Staphylococcal Protein A. Vaccine. 2014;32(4):464–469. doi:10.1016/j.vaccine.2013.11.054.
   PubMed Web of Science ®Google Scholar
• Garbacz K, Zarnowska S, Piechowicz L, et al. Pathogenicity Potential of Staphylococcus Pseudintermedius Strains Isolated from Canine Carriers and from Dogs with Infection Signs. Virulence. 2013;4(3):255–259. doi:10.4161/viru.23526.
   PubMed Web of Science ®Google Scholar
• Moodley A, Stegger M, Ben Zakour NL, et al. Tandem Repeat Sequence Analysis of Staphylococcal Protein a (Spa) Gene in Methicillin-Resistant Staphylococcus Pseudintermedius. Veterinary Microbiology. 2009;135(3):320–326.
   PubMed Web of Science ®Google Scholar
• Riley MC, Perreten V, Bemis DA, et al. Complete Genome Sequences of Three Important Methicillin-Resistant Clinical Isolates of Staphylococcus Pseudintermedius. Genome announcements. 2016;4(5):e01194–16. doi:10.1128/genomeA.01194-16.
   PubMedGoogle Scholar
• Lu T, Porter AR, Kennedy AD, et al. Phagocytosis and Killing of Staphylococcus Aureus by Human Neutrophils. Journal of Innate Immunity. 2014;6(5):639–649. doi:10.1159/000360478.
   PubMed Web of Science ®Google Scholar
• Salgado, M, Pignatari ACC, Bellinati-Pires R. Phagocytosis and Killing of Epidemic Methicillin-Resistant Staphylococcus Aureus by Human Neutrophils and Monocytes. Brazilian Journal of Infectious Diseases. 2004;8(1):80–89.
   PubMedGoogle Scholar
• Schneewind O, Model P, Fischetti VA. Sorting of Protein a to the Staphylococcal Cell Wall. Cell. 1992;70(2):267–281. doi:10.1016/0092-8674(92)90101-H.
   PubMed Web of Science ®Google Scholar
• Forsgren A, Sjöquist J. “Protein a” from Staphylococcus Aureus Iii. Reaction with Rabbit Γ-Globulin. The Journal of Immunology. 1967;99(1):19–24.
   PubMed Web of Science ®Google Scholar
• Geoghegan JA, Smith EJ, Speziale P, et al. Staphylococcus Pseudintermedius Expresses Surface Proteins That Closely Resemble Those from Staphylococcus Aureus. Veterinary Microbiology. 2009;138(3):345–352.
   PubMed Web of Science ®Google Scholar
• Smith EJ, Visai L, Kerrigan SW, et al. The Sbi Protein Is a Multifunctional Immune Evasion Factor of Staphylococcus Aureus. Infection and Immunity. 2011;79(9):3801–3809. doi:10.1128/IAI.05075-11.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jacobsson K, Vasi J, et al. A Second Igg-Binding Protein in Staphylococcus Aureus. Microbiology. 1998;144(4):985–991. doi:10.1099/00221287-144-4-985.
   PubMed Web of Science ®Google Scholar
• Atkins KL, Burman JD, Chamberlain ES, et al. S. Aureus Igg-Binding Proteins Spa and Sbi: Host Specificity and Mechanisms of Immune Complex Formation. Molecular Immunology. 2008;45(6):1600–1611. doi:10.1016/j.molimm.2007.10.021.
   PubMed Web of Science ®Google Scholar
• Begier E, Seiden DJ, Patton M, et al. Sa4ag, a 4-Antigen Staphylococcus Aureus Vaccine, Rapidly Induces High Levels of Bacteria-Killing Antibodies. Vaccine. 2017;35(8):1132–1139. doi:10.1016/j.vaccine.2017.01.024.
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Bertholet S, Grandi G. Inferring Reasons for the Failure of Staphylococcus Aureus Vaccines in Clinical Trials. The Staphylococci and Staphylococcal Pathogenesis. 2012;7.
   Google Scholar
• Institute CaLS. Clsi: Performance Standards for Antimicrobial Susceptibility Testing 26 ed. Wayne, PA; Clsi Supplement M100s. Vol. 36: 2016.
   Google Scholar
• Black CC, Eberlein LC, Solyman SM et al. The Role of Meca and Blaz Regulatory Elements in Meca Expression by Regional Clones of Methicillin-Resistant Staphylococcus Pseudintermedius. Vet Microbiol. 2011;151(3–4):345–53. doi:10.1016/j.vetmic.2011.03.026.
   PubMed Web of Science ®Google Scholar
• Oh H, Siano B, Diamond S. Neutrophil Isolation Protocol. JoVE (Journal of Visualized Experiments). 2008. (17):e745–e745.
   PubMedGoogle Scholar